Clinical Trial Update: Generic Tacrolimus in the Elderly - Prograf® vs Tacni® [Phase 4]

View source ↗

Summary

Phase 4 trial comparing generic tacrolimus (Tacni) with Prograf in elderly patients with end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Prograf (Tacrolimus)
• Tacni (tacrolimus)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: End Stage Renal Disease | Phase 4 | Status: COMPLETED